cortisol and glp-1 Claims circulating on social media warn that high levels can block the weight-loss effects of GLP-1, but obesity medicine experts say there is no evidence to support the idea. Tap the GLP-1 and Cortisol: Does Semaglutide

At present, seven trials have currently been reported for GLP-1 receptor agonists which include ELIXA (Evaluation of LIXisenatide in Acute coronary syndrome

The comparator arm was placebo, a GLP-1 RA (subcutaneous administration of semaglutide 1 mg once-weekly) and basal insulin in three [18, 19, 22], one [24, 25] and two trials [20, 21], respectively, while one trial included both a placebo arm and a GLP-1 RA arm (dulaglutide 1.5 mg once-weekly) [23]

[4] The FDA label also provides guidance on when to consider discontinuation: if a patient has not lost at least 5% of their initial body weight after 12 weeks on the 2.4 mg dose, stopping treatment may be appropriate as further benefits are unlikely

Always consult a qualified healthcare provider before starting any new treatment

Advertising or spam is also prohibited.

Maintenance support should be part of the plan, not an afterthought